HUNAN FANGSHENG PHARMACEUTICAL CO., LTD.

Andere Sprachen Hunan Fangsheng Pharmaceutical Co., Ltd.

Aktien

A14TTT

CNE100001VG6

603998

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 17.06.2024			% 5 Tage	% 1. Jan.
10,85 ^CNY	-0,28 %		-2,60 %	-1,00 %

19.04.	Hunan Fangsheng Pharmaceutical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2024	CI
10.04.	Fangsheng Pharmas Fabriken bestehen GMP-Inspektion	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19.04.
Fangsheng Pharma's Factories Pass GMP Inspection	10.04.
Fangsheng Pharma Gets 12.1 Million Yuan in Government Grants in January-March	08.04.
Fangsheng Pharma Withdraws Drug Registration Application For Headache Treatment	01.12.
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	31.08.23
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	20.04.23
Fangsheng Pharma's Drugs Placed in 2022 Chinese Drug Catalogue	20.01.23
Hunan Fangsheng Pharmaceutical Sees Up to 357% Surge in 2022 Profit; Shares Jump 3%	19.01.23
Hunan Fangsheng Pharma Unit to Resume Work After Leakage Forces Suspension	15.12.22
Hunan Fangsheng Pharmaceutical's Chinese Medicine Extraction Line Passes Regulatory Inspection	06.12.22
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30.10.22
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	30.08.22
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28.04.22
Hunan Fangsheng Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28.04.22
Hunan Fangsheng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 269.999999 million in funding	04.03.22
Hunan Fangsheng Pharmaceutical Co., Ltd. announced a financing transaction	04.03.22
Hunan Fangsheng Ruixin Pharmaceutical Co., Ltd. announced that it expects to receive CNY 160 million in funding from Hunan Fangsheng Pharmaceutical Co., Ltd., Changsha Xingchen Kangrui Venture Capital Partnership Enterprise (Limited Partnership), and another investor	30.12.21
China shares end lower as rising local COVID-19 cases drag consumer firms	27.12.21
Guo Jianjun agree to acquire 50% stake in Hunan Hengxing Pharmaceutical Technology Co., Ltd. from Hunan Fangsheng Pharmaceutical Co., Ltd. for CNY 9.4 million.	18.12.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Hunan Fangsheng Pharmaceutical Co., Ltd.

Aktien

A14TTT

CNE100001VG6

603998

Andere Sprachen

Filter